Evidence mapPaperPMID 41844361Full record

ArticleNucleic acids research2026

Three-dimensional structure of the palbociclib-HIV TAR complex.

Ravikanth Reddy Ramireddy, Venkata Vidalala, Bhawna Chaubey, Gregory L Olsen, Gabriele Varani

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ravikanth Reddy RamireddyDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, United States.
Venkata VidalalaDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, United States.
Bhawna ChaubeyDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, United States.
Gregory L OlsenDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, United States.ORCID 0000-0001-6039-8434
Gabriele VaraniDepartment of Chemistry, University of Washington, Seattle, WA 98195-1700, United States.ORCID 0000-0001-6642-7144

Funding

ncRNA: Structure, Interactions and InhibitionR35GM126942 · NIGMS · UNIVERSITY OF WASHINGTON · PI Gabriele Varani · 2018 to 2026
$6.0M
NIGMS NIH HHS 1R35GM126942NIGMS NIH HHS R35 GM126942NIH HHSWashington Research Foundation
6 · The paper itself

Abstract

We present the structure of the HIV-1 transactivation response (TAR) element bound to the kinase inhibitor palbociclib, a single-digit nM ligand and low nM inhibitor of assembly of the super elongation complex. The small molecule rearranges the RNA to create a deep binding pocket within a new structure of TAR. It displaces A22 to form an "intermolecular pair" with U40, generating a continuously stacked 11 base-pair helix, which includes three new base triples involving A22 itself and the UCU bulge nucleotides. Mutation of nucleotides within the binding pocket or small modifications of the small molecule that abrogate high-affinity binding also disrupt direct intermolecular contacts or interactions that stabilize the RNA structure required for binding. It is highly unlikely that such an extensive combination of sequence and structural requirements is duplicated anywhere else in the transcriptome and in a functional context. This structure demonstrates that RNA refolding in response to small molecule binding is key both to providing potent and specific interactions and to eliciting a biochemical response.

Indexed as

HIV-1HIV Long Terminal RepeatPiperazinesProtein Kinase InhibitorsPyridinesRNA, ViralBinding SitesModels, MolecularNucleic Acid ConformationpalbociclibPiperazinesProtein Kinase InhibitorsPyridinesRNA, Viral

Identifiers

PMID41844361
PMCPMC12995394

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.